New mechanism: collaborative procedure for registration of prequalified medicines
M
Principles for prioritizing dossiers within WHO prequalification of medicines
M
This note outlines the basic principles applied by PQP for prioritization of product dossier assessments and inspections of related sites within each therapeutic area.
Important note regarding WHO public assessment reports (WHOPARs)
M
The product information is an essential part of the medicinal product. The SmPC and PIL published with the WHOPAR have been quality assured by WHO experts and reflect the si